Response to allegations and some considerations on interferon treatment in Behçet's disease
- PMID: 14736807
- PMCID: PMC1771984
Response to allegations and some considerations on interferon treatment in Behçet's disease
Comment in
-
Final verdict of the Turkish Supreme Courts.Br J Ophthalmol. 2008 Mar;92(3):423. Br J Ophthalmol. 2008. PMID: 18303167 No abstract available.
Comment on
-
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.Br J Ophthalmol. 2003 Apr;87(4):423-31. doi: 10.1136/bjo.87.4.423. Br J Ophthalmol. 2003. PMID: 12642304 Free PMC article.
References
-
- Demiroglu H, Ozcebe OI, Barista I, et al. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet’s disease: a randomised trial. Lancet 2000;355:605–9. - PubMed
-
- Horton R. Retraction: Interferon alfa-2b…in Behçet’s disease. Lancet 2000;356:1292. - PubMed
-
- Sayek I. Behçet’s disease and interferon: flaws in research integrity of randomised trial. Lancet 2000;356:1351. - PubMed
-
- Turkish Republic, Ankara 3rd Court of General Criminal Jurisdiction; file no: 2003/256, decision no: 2003/335.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical